Drug Approvals Bounce Back as R & D Labs Churn Out New Winners Drug Approvals Bounce Back as R & D Labs Churn Out New Winners

The number of new drugs approved for sale in United States and Europe has bounced back this year, suggesting a marked slowdown in 2016 was an aberration rather than a sign of flagging research and development productivity.Reuters Health Information

Source: Medscape Medical News Headlines - May 26, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news